These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32692487)

  • 1. MASTL: A novel therapeutic target for Cancer Malignancy.
    Fatima I; Singh AB; Dhawan P
    Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation.
    Reshi I; Nisa MU; Farooq U; Gillani SQ; Bhat SA; Sarwar Z; Nabi N; Fazili KM; Andrabi S
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MASTL is the human orthologue of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis.
    Voets E; Wolthuis RM
    Cell Cycle; 2010 Sep; 9(17):3591-601. PubMed ID: 20818157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by PP1.
    Ma S; Vigneron S; Robert P; Strub JM; Cianferani S; Castro A; Lorca T
    J Cell Sci; 2016 Apr; 129(7):1329-39. PubMed ID: 26906418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O'Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A
    Oncogene; 2018 Aug; 37(33):4518-4533. PubMed ID: 29743597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.
    Álvarez-Fernández M; Sanz-Flores M; Sanz-Castillo B; Salazar-Roa M; Partida D; Zapatero-Solana E; Ali HR; Manchado E; Lowe S; VanArsdale T; Shields D; Caldas C; Quintela-Fandino M; Malumbres M
    Cell Death Differ; 2018 May; 25(5):828-840. PubMed ID: 29229993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis.
    Bisteau X; Lee J; Srinivas V; Lee JHS; Niska-Blakie J; Tan G; Yap SYX; Hom KW; Wong CK; Chae J; Wang LC; Kim J; Rancati G; Sobota RM; Tan CSH; Kaldis P
    Oncogene; 2020 Oct; 39(44):6816-6840. PubMed ID: 32978522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greatwall kinase at a glance.
    Castro A; Lorca T
    J Cell Sci; 2018 Oct; 131(20):. PubMed ID: 30355803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.
    Kumm EJ; Pagel O; Gambaryan S; Walter U; Zahedi RP; Smolenski A; Jurk K
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.
    Yoon YN; Choe MH; Jung KY; Hwang SG; Oh JS; Kim JS
    BMC Cancer; 2018 Jul; 18(1):716. PubMed ID: 29976159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling.
    Uppada SB; Gowrikumar S; Ahmad R; Kumar B; Szeglin B; Chen X; Smith JJ; Batra SK; Singh AB; Dhawan P
    Mol Cancer; 2018 Aug; 17(1):111. PubMed ID: 30068336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner.
    Sanz-Castillo B; Hurtado B; Vara-Ciruelos D; El Bakkali A; Hermida D; Salvador-Barbero B; Martínez-Alonso D; González-Martínez J; Santiveri C; Campos-Olivas R; Ximénez-Embún P; Muñoz J; Álvarez-Fernández M; Malumbres M
    EMBO J; 2023 Jan; 42(2):e110833. PubMed ID: 36354735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oncogenic Functions of MASTL Kinase.
    Marzec K; Burgess A
    Front Cell Dev Biol; 2018; 6():162. PubMed ID: 30555827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells.
    Rogers S; Fey D; McCloy RA; Parker BL; Mitchell NJ; Payne RJ; Daly RJ; James DE; Caldon CE; Watkins DN; Croucher DR; Burgess A
    J Cell Sci; 2016 Apr; 129(7):1340-54. PubMed ID: 26872783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint.
    Diril MK; Bisteau X; Kitagawa M; Caldez MJ; Wee S; Gunaratne J; Lee SH; Kaldis P
    PLoS Genet; 2016 Sep; 12(9):e1006310. PubMed ID: 27631493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
    Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
    Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MASTL(Greatwall) regulates DNA damage responses by coordinating mitotic entry after checkpoint recovery and APC/C activation.
    Wong PY; Ma HT; Lee HJ; Poon RY
    Sci Rep; 2016 Feb; 6():22230. PubMed ID: 26923777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PP2A-B55 Holoenzyme Regulation and Cancer.
    Goguet-Rubio P; Amin P; Awal S; Vigneron S; Charrasse S; Mechali F; Labbé JC; Lorca T; Castro A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33266510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Greatwall-PP2A axis in cell cycle control.
    Wang P; Malumbres M; Archambault V
    Methods Mol Biol; 2014; 1170():99-111. PubMed ID: 24906311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP2A/B55 and Fcp1 regulate Greatwall and Ensa dephosphorylation during mitotic exit.
    Hégarat N; Vesely C; Vinod PK; Ocasio C; Peter N; Gannon J; Oliver AW; Novák B; Hochegger H
    PLoS Genet; 2014 Jan; 10(1):e1004004. PubMed ID: 24391510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.